首页> 外文期刊>Kidney international. >Projecting renal replacement therapy|[ndash]|specific end-stage renal disease prevalence using registry data
【24h】

Projecting renal replacement therapy|[ndash]|specific end-stage renal disease prevalence using registry data

机译:使用注册数据预测肾脏替代治疗|特定疾病终末期肾脏疾病的患病率

获取原文
获取外文期刊封面目录资料

摘要

Projecting renal replacement therapy–specific end-stage renal disease prevalence using registry data. End-stage renal disease incidence and prevalence are increasing in many countries worldwide. Projections of ESRD prevalence are useful for forecasting future resource requirements, and organ failure registry databases are valuable for the development of appropriate projection models. We outline one method of generating renal replacement therapy (RRT)–specific ESRD prevalence projections based on data obtained from the Canadian Organ Replacement Register (CORR). To illustrate the methods, we present national RRT-specific prevalence projections for Canada to the year 2005. Continued large increases in ESRD incidence and prevalence are projected, particularly among diabetics. As of December 31, 1996, there were 17,807 patients receiving RRT in Canada. This number is projected to climb to 32,952 by the end of 2005, for a relative increase of 85% (average relative increase of 5.8% per year). Registry data are a useful basis for future health care planning.
机译:使用注册表数据预测肾脏替代治疗的特定终末期肾脏疾病患病率。在世界许多国家,终末期肾脏疾病的发病率和患病率正在增加。 ESRD患病率的预测对于预测未来的资源需求非常有用,器官衰竭登记数据库对于开发合适的预测模型非常有用。我们概述了一种基于从加拿大器官替代登记册(CORR)获得的数据来生成特定于肾脏替代治疗(RRT)的ESRD患病率预测的方法。为了说明这些方法,我们介绍了加拿大到2005年针对RRT的全国流行率预测。预计ESRD发病率和患病率将继续大幅增长,尤其是在糖尿病患者中。截至1996年12月31日,加拿大共有17,807名接受RRT的患者。到2005年底,这个数字预计将攀升至32,952,相对增长85%(平均每年相对增长5.8%)。注册表数据是将来卫生保健计划的有用基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号